Year |
Citation |
Score |
2024 |
Gao H, Zhang M, Baylis RA, Wang F, Björkegren JLM, Kovacic JJ, Ruusalepp A, Leeper NJ. Computational protocol to identify shared transcriptional risks and mutually beneficial compounds between diseases. Star Protocols. 5: 102883. PMID 38354084 DOI: 10.1016/j.xpro.2024.102883 |
0.341 |
|
2023 |
Baylis RA, Gao H, Wang F, Bell CF, Luo L, Björkegren JLM, Leeper NJ. Identifying shared transcriptional risk patterns between atherosclerosis and cancer. Iscience. 26: 107513. PMID 37636064 DOI: 10.1016/j.isci.2023.107513 |
0.448 |
|
2023 |
Bell CF, Lei X, Haas A, Baylis RA, Gao H, Luo L, Giordano SH, Wehner MR, Nead KT, Leeper NJ. Risk of Cancer After Diagnosis of Cardiovascular Disease. Jacc. Cardiooncology. 5: 431-440. PMID 37614573 DOI: 10.1016/j.jaccao.2023.01.010 |
0.417 |
|
2023 |
von Scheidt M, Bauer S, Ma A, Hao K, Kessler T, Vilne B, Wang Y, Hodonsky CJ, Ghosh SKB, Mokry M, Gao H, Kawai K, Sakamoto A, Kaiser J, Bongiovanni D, ... ... Leeper NJ, et al. Leukocytes carrying (CHIP) Mutations invade Human Atherosclerotic Plaques. Medrxiv : the Preprint Server For Health Sciences. PMID 37546840 DOI: 10.1101/2023.07.22.23292754 |
0.374 |
|
2022 |
Jarr KU, Ye J, Kojima Y, Ye Z, Gao H, Schmid S, Luo L, Baylis RA, Lotfi M, Lopez N, Eberhard AV, Smith BR, Weissman IL, Maegdefessel L, Leeper NJ. The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis. Nature Cardiovascular Research. 1: 253-262. PMID 35990913 DOI: 10.1038/s44161-022-00023-x |
0.343 |
|
2022 |
Gao H, Baylis RA, Luo L, Kojima Y, Bell CF, Ross EG, Wang F, Leeper NJ. Clustering cancers by shared transcriptional risk reveals novel targets for cancer therapy. Molecular Cancer. 21: 116. PMID 35585548 DOI: 10.1186/s12943-022-01592-y |
0.367 |
|
2021 |
Wang Y, Gao H, Wang F, Ye Z, Mokry M, Turner AW, Ye J, Koplev S, Luo L, Alsaigh T, Adkar SS, Elishaev M, Gao X, Maegdefessel L, Björkegren JLM, ... ... Leeper NJ, et al. Dynamic changes in chromatin accessibility are associated with the atherogenic transitioning of vascular smooth muscle cells. Cardiovascular Research. PMID 34849613 DOI: 10.1093/cvr/cvab347 |
0.321 |
|
Show low-probability matches. |